# Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults

> **NCT04472650** · PHASE1 · COMPLETED · sponsor: **BeiGene** · enrollment: 26 (actual)

## Conditions studied

- Tumor

## Interventions

- **DRUG:** Sitravatinib
- **DRUG:** Sitravatinib

## Key facts

- **NCT ID:** NCT04472650
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2020-11-09
- **Final completion:** 2020-11-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04472650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04472650, "Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04472650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*